EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 72 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38,836 | -24.0% | 43,300 | 0.0% | 0.00% | – |
| Q4 2022 | $51,094 | -81.1% | 43,300 | +20.3% | 0.00% | – |
| Q3 2022 | $271,000 | +29.7% | 36,000 | +8.4% | 0.00% | – |
| Q2 2022 | $209,000 | -14.3% | 33,200 | +12.9% | 0.00% | – |
| Q1 2022 | $244,000 | +59.5% | 29,400 | 0.0% | 0.00% | – |
| Q4 2021 | $153,000 | -26.8% | 29,400 | -6.1% | 0.00% | – |
| Q3 2021 | $209,000 | -21.7% | 31,300 | 0.0% | 0.00% | – |
| Q2 2021 | $267,000 | +0.4% | 31,300 | +4.3% | 0.00% | – |
| Q1 2021 | $266,000 | -27.9% | 30,000 | 0.0% | 0.00% | – |
| Q4 2020 | $369,000 | +51.2% | 30,000 | 0.0% | 0.00% | – |
| Q3 2020 | $244,000 | -15.3% | 30,000 | 0.0% | 0.00% | – |
| Q2 2020 | $288,000 | +119.8% | 30,000 | +55.4% | 0.00% | – |
| Q1 2020 | $131,000 | -14.4% | 19,300 | +87.4% | 0.00% | – |
| Q4 2019 | $153,000 | +44.3% | 10,300 | 0.0% | 0.00% | – |
| Q3 2019 | $106,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |